跳至主要内容
临床试验/NCT02066740
NCT02066740已完成不适用

EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study

Medtronic Endovascular1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2014年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
34
试验地点
1
主要终点
Absence of Stent Elongation

研究概览

简要总结

The purpose of this study is to collect acute confirmatory data to evaluate technical success and acute safety of the EverFlex™ self-expanding peripheral stent with Entrust™ delivery system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has stenotic, restenotic (from PTA or adjunct therapy, not including stents or stent grafts),
  • or occluded lesion(s) located in the superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) suitable for primary stenting.

排除标准

  • Has undergone previous implantation of stent(s) or stent graft(s) in the target vessel.

研究组 & 干预措施

EverFlex™ stent with Entrust™ delivery system

Experimental

干预措施: EverFlex™ stent with Entrust™ delivery system (Device)

结局指标

主要结局

Absence of Stent Elongation

时间窗: Intra operative

Absence of stent elongation is achieved when the implanted stent length does not exceed the allowed stent length

Successful Stent Deployment

时间窗: Procedure

Successful stent deployment to be assessed based on stent delivery, lesion coverage and accuracy of deployment.

次要结局

未报告次要终点

研究者

发起方
Medtronic Endovascular
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

EverFlex™ Self-expanding Peripheral Stent With... | 临床试验